Wyles D, Poordad F, Wang S. et al. Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial. Hepatology 2017 DOI: 10.1002/hep.29541.
Download Bibliographical Data
We do not assume any responsibility for the contents of the web pages of other providers.